Cocrystal Pharma Inc.
COCP | NASDAQ
$1.22
+$0.01 (+0.83%)
At close: Sep 21, 2026, 3:59 PM ET
$1.19
-$0.03 (-2.46%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Market Data
Market Cap $16.68M
Enterprise Value $15.92M
Beta 1.48
Average Volume 89.52K
Shares Outstanding (Diluted) 13.79M
Shares Change YoY 35.52%
Institutional Ownership 5.63%
Exchange NASDAQ
ISIN US19188J4094
Price Performance
Price Change 1M 2.5%
Price Change 3M 15.1%
Price Change 6M 13.0%
Price Change YTD 22.9%
Price Change 1Y -6.2%
Price Change 3Y -35.8%
Price Change 5Y -90.1%
1M CAGR (ann.) 17.5%
1Y CAGR (ann.) -0.8%
5Y CAGR (ann.) -37.9%
All-Time CAGR -36.5%
Valuation
PE Ratio -1.58
Forward PE N/A
PEG Ratio -0.03
Forward PEG 0.10
PS Ratio 50.76
Forward PS N/A
PB Ratio 16.05
P/FCF Ratio -2.05
P/Adj. FCF Ratio -2.00
P/OCF Ratio -2.07
EV/Sales 48.25
EV/EBIT -1.60
EV/EBITDA -1.68
EV/FCF -1.95
Earnings Yield -63.1%
FCF Yield -48.7%
Adj. FCF Yield -50.1%
Financial Health
Net Cash $2.17M
Total Debt $1.34M
Cash & Short-Term Investments $2.17M
Total Assets $4.65M
Current Ratio 1.24
Quick Ratio 1.24
Debt / Equity Ratio 1.28
Debt / EBITDA -0.14
Debt / FCF -0.16
OCF / Debt -6.07
Interest Coverage 0.00
Altman Z-Score -108.76
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 205.8%
Operating Profit Margin -3063.6%
EBITDA Margin -2876.7%
Net Profit Margin -3011.5%
FCF Margin -2470.7%
Adj. FCF Margin -2541.0%
SBC / Revenue 70.3%
SBC Impact (per share) -2.9%
Returns
Return on Assets -213.8%
Return on Equity -207.5%
Return on Invested Capital -423.9%
Return on Capital Employed -497.3%
Return on Tangible Assets -213.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y -19.9%
Revenue CAGR 10Y -21.8%
EPS CAGR 3Y 39.7%
EPS CAGR 5Y 51.9%
EPS CAGR 10Y 30.3%
FCF CAGR 3Y 25.6%
FCF CAGR 5Y 16.7%
FCF CAGR 10Y -7.7%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-8.14M
Free Cash Flow $-8.15M
Adj. Free Cash Flow $-8.39M
FCF Per Share -$0.59
OCF Per Share -$0.59
OCF/S Ratio -2466.9%
Income Statement
Revenue $330K
Gross Profit $679K
Operating Income $-10.11M
EBITDA $-9.49M
Net Income $-9.94M
EPS (Diluted) -$0.77
Revenue / Employee $33K
Profit / Employee $-993.8K
Employees 10
Add to Watchlist
Select watchlists to add or remove COCP